Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020139843 - ENGINEERED HEPATITIS B CORE POLYPEPTIDE

Publication Number WO/2020/139843
Publication Date 02.07.2020
International Application No. PCT/US2019/068370
International Filing Date 23.12.2019
IPC
C07K 1/113 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
1General processes for the preparation of peptides
107by chemical modification of precursor peptides
113without change of the primary structure
C07K 1/107 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
1General processes for the preparation of peptides
107by chemical modification of precursor peptides
C07K 14/005 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
A61K 9/51 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
48Preparations in capsules, e.g. of gelatin, of chocolate
50Microcapsules
51Nanocapsules
A61K 38/16 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
CPC
C07K 14/005
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
C07K 14/02
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
01DNA viruses
02Hepadnaviridae, e.g. hepatitis B virus
C12N 2730/10122
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2730Reverse Transcribing DNA Viruses
00011Reverse Transcribing DNA Viruses
10011Hepadnaviridae
10111Orthohepadnavirus, e.g. hepatitis B virus
10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N 2730/10123
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2730Reverse Transcribing DNA Viruses
00011Reverse Transcribing DNA Viruses
10011Hepadnaviridae
10111Orthohepadnavirus, e.g. hepatitis B virus
10123Virus like particles [VLP]
C12N 2730/10142
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2730Reverse Transcribing DNA Viruses
00011Reverse Transcribing DNA Viruses
10011Hepadnaviridae
10111Orthohepadnavirus, e.g. hepatitis B virus
10141Use of virus, viral particle or viral elements as a vector
10142virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N 7/00
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
7Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Applicants
  • THE BOARD OF TRUSTEE OF THE LELAND STANFORD JUNIOR UNIVERSITY [US]/[US]
Inventors
  • SWARTZ, James R.
  • MATHEW, Rinchu
  • ROHOVIE, Marcus John
  • NAGASAWA, Maya
Agents
  • SHERWOOD, Pamela J.
Priority Data
62/785,86628.12.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ENGINEERED HEPATITIS B CORE POLYPEPTIDE
(FR) POLYPEPTIDE NOYAU DE L'HÉPATITE B GÉNÉTIQUEMENT MODIFIÉ
Abstract
(EN)
Genetically modified HBc polypeptides are provided.
(FR)
L'invention concerne des polypeptides HBc génétiquement modifiés.
Related patent documents
EP2019904608This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau